Abstract:MicroRNAs (miRNAs) have emerged as critical regulators of gene expression through translational inhibition and RNA decay and have been implicated in the regulation of cellular differentiation, proliferation, angiogenesis, and apoptosis. In this study, we analyzed global miRNA and mRNA microarrays to predict novel miRNA-mRNA interactions in human embryonic stem cells and induced pluripotent stem cells (iPSCs). In particular, we demonstrate a regulatory feedback loop between the miR-302 cluster and two transcription factors, NR2F2 and OCT4. Our data show high expression of miR-302 and OCT4 in pluripotent cells, while NR2F2 is expressed exclusively in differentiated cells. Target analysis predicts that NR2F2 is a direct target of miR-302, which we experimentally confirm by reporter luciferase assays and real-time polymerase chain reaction. We also demonstrate that NR2F2 directly inhibits the activity of the OCT4 promoter and thus diminishes the positive feedback loop between OCT4 and miR-302. Importantly, higher reprogramming efficiencies were obtained when we reprogrammed human adipose-derived stem cells into iPSCs using four factors (KLF4, C-MYC, OCT4, and SOX2) plus miR-302 (this reprogramming cocktail is hereafter referred to as "KMOS3") when compared to using four factors ("KMOS"). Furthermore, shRNA knockdown of NR2F2 mimics the over-expression of miR-302 by also enhancing reprogramming efficiency. Interestingly, we were unable to generate iPSCs from miR-302a/b/c/d alone, which is in contrast to previous publications that have reported that miR-302 by itself can reprogram human skin cancer cells and human hair follicle cells. Taken together, these findings demonstrate that miR-302 inhibits NR2F2 and promotes pluripotency through indirect positive regulation of OCT4. This feedback loop represents an important new mechanism for understanding and inducing pluripotency in somatic cells. STEM CELLS 2013;31:259-268

Elevated P53 Activities Restrict Differentiation Potential of MicroRNA-Deficient Pluripotent Stem Cells

P53 Induces Differentiation of Mouse Embryonic Stem Cells by Suppressing Nanog Expression

miR-106b regulates the proliferation and differentiation of neural stem/progenitor cells through Tp53inp1-Tp53-Cdkn1a axis

A Genomewide Study Identifies the Wnt Signaling Pathway As a Major Target of P53 in Murine Embryonic Stem Cells

p53 inactivation unmasks histone methylation-independent WDR5 functions that drive self-renewal and differentiation of pluripotent stem cells.

p53 regulates neural stem cell proliferation and differentiation via BMP-Smad1 signaling and Id1.

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

Pten-mediated Gsk3β Modulates the Naïve Pluripotency Maintenance in Embryonic Stem Cells

Mir-146A-3p Suppressed the Differentiation of Hamscs into Schwann Cells Via Inhibiting the Expression of ERBB2

Canonical Micrornas Enable Differentiation, Protect Against DNA Damage, and Promote Cholesterol Biosynthesis in Neural Stem Cells.

Oct4 Maintains the Pluripotency of Human Embryonic Stem Cells by Inactivating P53 Through Sirt1-Mediated Deacetylation

Regulation of Apoptosis and Differentiation by P53 in Human Embryonic Stem Cells*

Mir-138 Promotes Induced Pluripotent Stem Cell Generation Through the Regulation of the P53 Signaling

Pluripotency-associated miR-290/302 family of microRNAs promote the dismantling of naive pluripotency

A novel microRNA-based strategy to expand the differentiation potency of stem cells

p57 Suppresses the Pluripotency and Proliferation of Mouse Embryonic Stem Cells by Positively Regulating p53 Activation

Deficiency of microRNA miR-34a expands cell fate potential in pluripotent stem cells

MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.

Increase Developmental Plasticity Of Human Keratinocytes With Gene Suppression

Transient Exposure to Mir-203 Enhances the Differentiation Capacity of Established Pluripotent Stem Cells

Mir-495 Suppresses Mesendoderm Differentiation of Mouse Embryonic Stem Cells Via the Direct Targeting of Dnmt3a